Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

COVID-19 coronavirus

With structured reporting, chest x-rays have high likelihood of predicting positive RT-PCR test results

To help conserve resources, Irish imaging experts devised a systematic approach for reporting the likelihood of COVID-19 pneumonia on CXR. 

start date 2021 track calendar

The American College of Radiology will host next year’s annual meeting entirely online

ACR said it made the "difficult decision" with its members' safety in mind. The event will take place May 15-19.

Thumbnail

Researchers call for optimized shielding efforts after study shows imaging radiation may boost testicular cancer risk

Individuals exposed to diagnostic radiation in the first decade of their life face an increased risk of developing the disease, Penn Medicine experts reported recently.

Thumbnail

Woman diagnosed with stage 3 breast cancer sues over misread mammograms

Sonja Wowk, 63, is the sixth woman to file suit against Michael Bigg and the Allison Breast Cancer.

Thumbnail

Radiologists must assume leading role in ultrasound governance, training, medical societies urge

The specialty should also work to ensure that hygienic measures are in place to prevent contamination, experts advised. 

Thumbnail

Pairing DBT with synthetic mammography beats traditional ‘one size fits all’ breast screening approach

The combination detected more cancers overall and a larger crop of early stage cases compared to digital mammography, Italian researchers reported in Radiology.

Many IR procedures could not be delayed during the pandemic due to their ‘central role in patient care’

Interventional rad volumes didn't fall as hard as diagnostic imaging totals which should spark conversation about redefining "essential" procedures.

FDA expert panel votes against Biogen’s Alzheimer’s drug, dashing latest hopes for treatment

Alzheimer's Association President and CEO Harry Johns said the vote was disappointing, claiming publicly released data on aducanumab justified its federal approval.